Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor
Background: Protein S (PS) has direct anticoagulant activity, independently of activated protein C (APC). The mechanisms underlying this activity remain unclear, because PS preparations differ in activity, giving rise to conflicting results. Some purification procedures result in loss of intramolecu...
Gespeichert in:
Veröffentlicht in: | Journal of thrombosis and haemostasis 2010-09, Vol.8 (9), p.1976-1985 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1985 |
---|---|
container_issue | 9 |
container_start_page | 1976 |
container_title | Journal of thrombosis and haemostasis |
container_volume | 8 |
creator | FERNANDES, N. MOSNIER, L. O. TONNU, L. HEEB, M. J. |
description | Background: Protein S (PS) has direct anticoagulant activity, independently of activated protein C (APC). The mechanisms underlying this activity remain unclear, because PS preparations differ in activity, giving rise to conflicting results. Some purification procedures result in loss of intramolecular Zn2+, which is essential for inhibition of prothrombinase. Objective: To investigate the inhibition of extrinsic factor (F)Xase by Zn2+‐containing PS. Methods: Purified component extrinsic FXase assays were used to determine FXa generation in the presence and absence of PS and/or tissue factor pathway inhibitor (TFPI). Binding assays, immunoblots and thrombin generation assays in plasma supported the FXase data. Results: Zn2+‐containing PS potently inhibited extrinsic FXase in the presence of saturating phospholipids, independently of TFPI, whereas inhibition of extrinsic FXase by Zn2+‐deficient PS required TFPI. Immunoblots for FXa and functional assays showed that Zn2+‐containing PS inhibited primarily the quantity of FXa formed by tissue factor (TF)–FVIIa, rather than FXa amidolytic activity. Zn2+‐containing PS, but not Zn2+‐deficient PS, bound to TF with high affinity (Kd app = 41 nm) and targeted TF function. Binding of PS to FVIIa was negligible, whereas PS showed appreciable binding to FX. Increasing FX concentrations 10‐fold reduced PS inhibition five‐fold, suggesting that PS inhibition of FXase is FX‐dependent. PS also exhibited TFPI‐independent and APC‐independent anticoagulant activity during TF‐initiated thrombin generation in plasma. Conclusions: PS that retains native Zn2+ also retains anticoagulant functions independently of APC and TFPI. Inhibition of extrinsic FXase by PS at saturating levels of phospholipids depends on PS retention of intramolecular Zn2+, interaction with FX, and, particularly, interaction with TF. |
doi_str_mv | 10.1111/j.1538-7836.2010.03919.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2955986</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>762285731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4039-61678da749fa52f107ecd38d65d9b1f88277236da1a0ed80200fd7f33b848c3</originalsourceid><addsrcrecordid>eNqNkUtuFDEURa0IRD6whahmDFB3_Kkq2wOQUARJUCQGySBiYrn9SbtVbRe2O-kewRKyhKwlS8lKcNEfwSwe2E9-91w_6wJQIThGZZ3MxqghbEQZaccYlltIOOLj5R442DVebWtOyD44TGkGIeINhm_APoY1xzVFB-DXD48_PP9-UMFn6bzzt1UfQzbOPz1eVc5P3cTlVJlljs4npyorVQ7x6fGmQKV0dzIPkArzvjPLQmjTm7L53K2qYKvsUlqYDVb1Mk_v5WprHOJb8NrKLpl3m_MIXH39cn16Prr8fnZx-vlypOryt1GLWsq0pDW3ssEWQWqUJky3jeYTZBnDlGLSaokkNJpBDKHV1BIyYTVT5Ah8Wrv2i8ncaFWmi7ITfXRzGVciSCf-73g3FbfhTmDeNJy1xeD9xiCGnwuTspi7pEzXSW_CIgnaYswaSlBRsrVSxZBSNHb3CoJiCE_MxJCLGDISQ3jib3hiWdDjf6fcgdu0iuDjWnDvOrN6sbH4dn0-VOQPR_KwcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>762285731</pqid></control><display><type>article</type><title>Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>FERNANDES, N. ; MOSNIER, L. O. ; TONNU, L. ; HEEB, M. J.</creator><creatorcontrib>FERNANDES, N. ; MOSNIER, L. O. ; TONNU, L. ; HEEB, M. J.</creatorcontrib><description>Background: Protein S (PS) has direct anticoagulant activity, independently of activated protein C (APC). The mechanisms underlying this activity remain unclear, because PS preparations differ in activity, giving rise to conflicting results. Some purification procedures result in loss of intramolecular Zn2+, which is essential for inhibition of prothrombinase. Objective: To investigate the inhibition of extrinsic factor (F)Xase by Zn2+‐containing PS. Methods: Purified component extrinsic FXase assays were used to determine FXa generation in the presence and absence of PS and/or tissue factor pathway inhibitor (TFPI). Binding assays, immunoblots and thrombin generation assays in plasma supported the FXase data. Results: Zn2+‐containing PS potently inhibited extrinsic FXase in the presence of saturating phospholipids, independently of TFPI, whereas inhibition of extrinsic FXase by Zn2+‐deficient PS required TFPI. Immunoblots for FXa and functional assays showed that Zn2+‐containing PS inhibited primarily the quantity of FXa formed by tissue factor (TF)–FVIIa, rather than FXa amidolytic activity. Zn2+‐containing PS, but not Zn2+‐deficient PS, bound to TF with high affinity (Kd app = 41 nm) and targeted TF function. Binding of PS to FVIIa was negligible, whereas PS showed appreciable binding to FX. Increasing FX concentrations 10‐fold reduced PS inhibition five‐fold, suggesting that PS inhibition of FXase is FX‐dependent. PS also exhibited TFPI‐independent and APC‐independent anticoagulant activity during TF‐initiated thrombin generation in plasma. Conclusions: PS that retains native Zn2+ also retains anticoagulant functions independently of APC and TFPI. Inhibition of extrinsic FXase by PS at saturating levels of phospholipids depends on PS retention of intramolecular Zn2+, interaction with FX, and, particularly, interaction with TF.</description><identifier>ISSN: 1538-7933</identifier><identifier>ISSN: 1538-7836</identifier><identifier>EISSN: 1538-7836</identifier><identifier>DOI: 10.1111/j.1538-7836.2010.03919.x</identifier><identifier>PMID: 20492471</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Anticoagulants - chemistry ; Anticoagulants - therapeutic use ; blood coagulation ; extrinsic pathway ; Factor X - chemistry ; Factor Xa - chemistry ; Humans ; Kinetics ; Lipoproteins - chemistry ; Phospholipids - chemistry ; Protein Binding ; Protein C - chemistry ; Protein S - metabolism ; Recombinant Proteins - chemistry ; Thromboplastin - chemistry ; Time Factors ; Zinc - chemistry ; Zinc - pharmacology ; zinc metalloprotein</subject><ispartof>Journal of thrombosis and haemostasis, 2010-09, Vol.8 (9), p.1976-1985</ispartof><rights>2010 International Society on Thrombosis and Haemostasis</rights><rights>2010 International Society on Thrombosis and Haemostasis.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4039-61678da749fa52f107ecd38d65d9b1f88277236da1a0ed80200fd7f33b848c3</citedby><cites>FETCH-LOGICAL-c4039-61678da749fa52f107ecd38d65d9b1f88277236da1a0ed80200fd7f33b848c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20492471$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FERNANDES, N.</creatorcontrib><creatorcontrib>MOSNIER, L. O.</creatorcontrib><creatorcontrib>TONNU, L.</creatorcontrib><creatorcontrib>HEEB, M. J.</creatorcontrib><title>Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor</title><title>Journal of thrombosis and haemostasis</title><addtitle>J Thromb Haemost</addtitle><description>Background: Protein S (PS) has direct anticoagulant activity, independently of activated protein C (APC). The mechanisms underlying this activity remain unclear, because PS preparations differ in activity, giving rise to conflicting results. Some purification procedures result in loss of intramolecular Zn2+, which is essential for inhibition of prothrombinase. Objective: To investigate the inhibition of extrinsic factor (F)Xase by Zn2+‐containing PS. Methods: Purified component extrinsic FXase assays were used to determine FXa generation in the presence and absence of PS and/or tissue factor pathway inhibitor (TFPI). Binding assays, immunoblots and thrombin generation assays in plasma supported the FXase data. Results: Zn2+‐containing PS potently inhibited extrinsic FXase in the presence of saturating phospholipids, independently of TFPI, whereas inhibition of extrinsic FXase by Zn2+‐deficient PS required TFPI. Immunoblots for FXa and functional assays showed that Zn2+‐containing PS inhibited primarily the quantity of FXa formed by tissue factor (TF)–FVIIa, rather than FXa amidolytic activity. Zn2+‐containing PS, but not Zn2+‐deficient PS, bound to TF with high affinity (Kd app = 41 nm) and targeted TF function. Binding of PS to FVIIa was negligible, whereas PS showed appreciable binding to FX. Increasing FX concentrations 10‐fold reduced PS inhibition five‐fold, suggesting that PS inhibition of FXase is FX‐dependent. PS also exhibited TFPI‐independent and APC‐independent anticoagulant activity during TF‐initiated thrombin generation in plasma. Conclusions: PS that retains native Zn2+ also retains anticoagulant functions independently of APC and TFPI. Inhibition of extrinsic FXase by PS at saturating levels of phospholipids depends on PS retention of intramolecular Zn2+, interaction with FX, and, particularly, interaction with TF.</description><subject>Anticoagulants - chemistry</subject><subject>Anticoagulants - therapeutic use</subject><subject>blood coagulation</subject><subject>extrinsic pathway</subject><subject>Factor X - chemistry</subject><subject>Factor Xa - chemistry</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Lipoproteins - chemistry</subject><subject>Phospholipids - chemistry</subject><subject>Protein Binding</subject><subject>Protein C - chemistry</subject><subject>Protein S - metabolism</subject><subject>Recombinant Proteins - chemistry</subject><subject>Thromboplastin - chemistry</subject><subject>Time Factors</subject><subject>Zinc - chemistry</subject><subject>Zinc - pharmacology</subject><subject>zinc metalloprotein</subject><issn>1538-7933</issn><issn>1538-7836</issn><issn>1538-7836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtuFDEURa0IRD6whahmDFB3_Kkq2wOQUARJUCQGySBiYrn9SbtVbRe2O-kewRKyhKwlS8lKcNEfwSwe2E9-91w_6wJQIThGZZ3MxqghbEQZaccYlltIOOLj5R442DVebWtOyD44TGkGIeINhm_APoY1xzVFB-DXD48_PP9-UMFn6bzzt1UfQzbOPz1eVc5P3cTlVJlljs4npyorVQ7x6fGmQKV0dzIPkArzvjPLQmjTm7L53K2qYKvsUlqYDVb1Mk_v5WprHOJb8NrKLpl3m_MIXH39cn16Prr8fnZx-vlypOryt1GLWsq0pDW3ssEWQWqUJky3jeYTZBnDlGLSaokkNJpBDKHV1BIyYTVT5Ah8Wrv2i8ncaFWmi7ITfXRzGVciSCf-73g3FbfhTmDeNJy1xeD9xiCGnwuTspi7pEzXSW_CIgnaYswaSlBRsrVSxZBSNHb3CoJiCE_MxJCLGDISQ3jib3hiWdDjf6fcgdu0iuDjWnDvOrN6sbH4dn0-VOQPR_KwcA</recordid><startdate>201009</startdate><enddate>201009</enddate><creator>FERNANDES, N.</creator><creator>MOSNIER, L. O.</creator><creator>TONNU, L.</creator><creator>HEEB, M. J.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201009</creationdate><title>Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor</title><author>FERNANDES, N. ; MOSNIER, L. O. ; TONNU, L. ; HEEB, M. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4039-61678da749fa52f107ecd38d65d9b1f88277236da1a0ed80200fd7f33b848c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anticoagulants - chemistry</topic><topic>Anticoagulants - therapeutic use</topic><topic>blood coagulation</topic><topic>extrinsic pathway</topic><topic>Factor X - chemistry</topic><topic>Factor Xa - chemistry</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Lipoproteins - chemistry</topic><topic>Phospholipids - chemistry</topic><topic>Protein Binding</topic><topic>Protein C - chemistry</topic><topic>Protein S - metabolism</topic><topic>Recombinant Proteins - chemistry</topic><topic>Thromboplastin - chemistry</topic><topic>Time Factors</topic><topic>Zinc - chemistry</topic><topic>Zinc - pharmacology</topic><topic>zinc metalloprotein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FERNANDES, N.</creatorcontrib><creatorcontrib>MOSNIER, L. O.</creatorcontrib><creatorcontrib>TONNU, L.</creatorcontrib><creatorcontrib>HEEB, M. J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FERNANDES, N.</au><au>MOSNIER, L. O.</au><au>TONNU, L.</au><au>HEEB, M. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor</atitle><jtitle>Journal of thrombosis and haemostasis</jtitle><addtitle>J Thromb Haemost</addtitle><date>2010-09</date><risdate>2010</risdate><volume>8</volume><issue>9</issue><spage>1976</spage><epage>1985</epage><pages>1976-1985</pages><issn>1538-7933</issn><issn>1538-7836</issn><eissn>1538-7836</eissn><abstract>Background: Protein S (PS) has direct anticoagulant activity, independently of activated protein C (APC). The mechanisms underlying this activity remain unclear, because PS preparations differ in activity, giving rise to conflicting results. Some purification procedures result in loss of intramolecular Zn2+, which is essential for inhibition of prothrombinase. Objective: To investigate the inhibition of extrinsic factor (F)Xase by Zn2+‐containing PS. Methods: Purified component extrinsic FXase assays were used to determine FXa generation in the presence and absence of PS and/or tissue factor pathway inhibitor (TFPI). Binding assays, immunoblots and thrombin generation assays in plasma supported the FXase data. Results: Zn2+‐containing PS potently inhibited extrinsic FXase in the presence of saturating phospholipids, independently of TFPI, whereas inhibition of extrinsic FXase by Zn2+‐deficient PS required TFPI. Immunoblots for FXa and functional assays showed that Zn2+‐containing PS inhibited primarily the quantity of FXa formed by tissue factor (TF)–FVIIa, rather than FXa amidolytic activity. Zn2+‐containing PS, but not Zn2+‐deficient PS, bound to TF with high affinity (Kd app = 41 nm) and targeted TF function. Binding of PS to FVIIa was negligible, whereas PS showed appreciable binding to FX. Increasing FX concentrations 10‐fold reduced PS inhibition five‐fold, suggesting that PS inhibition of FXase is FX‐dependent. PS also exhibited TFPI‐independent and APC‐independent anticoagulant activity during TF‐initiated thrombin generation in plasma. Conclusions: PS that retains native Zn2+ also retains anticoagulant functions independently of APC and TFPI. Inhibition of extrinsic FXase by PS at saturating levels of phospholipids depends on PS retention of intramolecular Zn2+, interaction with FX, and, particularly, interaction with TF.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>20492471</pmid><doi>10.1111/j.1538-7836.2010.03919.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1538-7933 |
ispartof | Journal of thrombosis and haemostasis, 2010-09, Vol.8 (9), p.1976-1985 |
issn | 1538-7933 1538-7836 1538-7836 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2955986 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Anticoagulants - chemistry Anticoagulants - therapeutic use blood coagulation extrinsic pathway Factor X - chemistry Factor Xa - chemistry Humans Kinetics Lipoproteins - chemistry Phospholipids - chemistry Protein Binding Protein C - chemistry Protein S - metabolism Recombinant Proteins - chemistry Thromboplastin - chemistry Time Factors Zinc - chemistry Zinc - pharmacology zinc metalloprotein |
title | Zn2+‐containing protein S inhibits extrinsic factor X‐activating complex independently of tissue factor pathway inhibitor |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A09%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Zn2+%E2%80%90containing%20protein%C2%A0S%20inhibits%20extrinsic%20factor%C2%A0X%E2%80%90activating%20complex%20independently%20of%20tissue%20factor%20pathway%20inhibitor&rft.jtitle=Journal%20of%20thrombosis%20and%20haemostasis&rft.au=FERNANDES,%20N.&rft.date=2010-09&rft.volume=8&rft.issue=9&rft.spage=1976&rft.epage=1985&rft.pages=1976-1985&rft.issn=1538-7933&rft.eissn=1538-7836&rft_id=info:doi/10.1111/j.1538-7836.2010.03919.x&rft_dat=%3Cproquest_pubme%3E762285731%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=762285731&rft_id=info:pmid/20492471&rfr_iscdi=true |